Literature DB >> 17712098

Depression in Primary Progressive Aphasia.

Jennifer Medina1, Sandra Weintraub.   

Abstract

Primary Progressive Aphasia (PPA) is a clinical dementia syndrome in which language functions decline over time while other cognitive domains remain relatively preserved for at least 2 years. Because PPA patients suffer progressive interference with communication despite relatively preserved memory, reasoning, and insight, there is reason to believe they may experience depression. Geriatric Depression Scale (GDS) scores from PPA patients and normal controls were compared, the relationship between GDS and neuropsychological test scores was examined, and responses to items on the GDS were explored and grouped by the GDS factor structure. A significant proportion of PPA patients scored in the clinically depressed range. Although PPA patients as a group were not clinically depressed, they reported more symptoms of depression than controls, and the number of symptoms correlated with severity of naming impairment in depressed PPA patients. Symptoms of social withdrawal and lack of mental and physical energy were most common, suggesting that patients with PPA should be evaluated for depression so that they may be appropriately treated.

Entities:  

Mesh:

Year:  2007        PMID: 17712098     DOI: 10.1177/0891988707303603

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  21 in total

1.  Quantitative classification of primary progressive aphasia at early and mild impairment stages.

Authors:  M-Marsel Mesulam; Christina Wieneke; Cynthia Thompson; Emily Rogalski; Sandra Weintraub
Journal:  Brain       Date:  2012-04-23       Impact factor: 13.501

2.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

Review 3.  An update on primary progressive aphasia.

Authors:  Emily Rogalski; Marsel Mesulam
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

4.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

5.  Neuropsychiatric aspects of primary progressive aphasia.

Authors:  Yasaman Fatemi; Bradley F Boeve; Joseph Duffy; Ronald C Petersen; David S Knopman; Vladimir Cejka; Glenn E Smith; Yonas E Geda
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

Review 6.  The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias.

Authors:  Darby Morhardt; Sandra Weintraub; Becky Khayum; Jaimie Robinson; Jennifer Medina; Mary O'Hara; Marsel Mesulam; Emily J Rogalski
Journal:  Psychiatr Clin North Am       Date:  2015-03-07

7.  Development of a Psycho-Educational Support Program for Individuals with Primary Progressive Aphasia and their Care-Partners.

Authors:  Darby J Morhardt; Mary C O'Hara; Kristine Zachrich; Christina Wieneke; Emily J Rogalski
Journal:  Dementia (London)       Date:  2017-03-22

Review 8.  The non-fluent/agrammatic variant of primary progressive aphasia.

Authors:  Murray Grossman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

9.  Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Sarah Jane Banks; Sandra Weintraub
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 10.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.